Radiopharm Theranostics Limited

RADX · NASDAQ
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income$0-$48-$35-$30
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0$0$0$0
Other Non-Cash-$37$25$11$20
Operating Cash Flow-$37-$23-$23-$10
Investing Activities
PP&E Inv.$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$2-$0-$1-$28
Investing Cash Flow$2-$0-$2-$28
Financing Activities
Debt Repay.-$2$2$0-$0
Stock Issued$54$30$10$70
Stock Repurch.$0-$2-$1-$5
Dividends Paid$0$0$0$0
Other Fin. Act.-$7-$0$0$0
Financing Cash Flow$45$30$9$65
Forex Effect-$0-$0$0$0
Net Chg. in Cash$11$7-$15$27
Supplemental Information
Beg. Cash$19$12$27$0
End Cash$29$19$12$27
Free Cash Flow-$37-$23-$25-$38
Radiopharm Theranostics Limited (RADX) Financial Statements & Key Stats | AlphaPilot